Intracellular amyloid-β in Alzheimer's disease

LaFerla, Frank M., Green, Kim N., Oddo, Salvatore·2007·Nature Reviews Neuroscience

Cited by (1,005)

Items 601–700 of 1,005

  1. Neural stem/progenitor cells in Alzheimer's disease.
    Gizem Tincer, Violeta Mashkaryan, Prabesh Bhattarai, Çağhan Kızıl · 2016 · Europe PMC (PubMed Central)
  2. Synaptophysin depletion and intraneuronal Aβ in organotypic hippocampal slice cultures from huAPP transgenic mice
    Claire S. Durrant, Michael P. Coleman · 2016 · Molecular Neurodegeneration
  3. Silymarin’s Inhibition and Treatment Effects for Alzheimer’s Disease
    Hong Wei Guo, Hui Cao, Xiaowei Cui, Wenxiu Zheng, Shanshan Wang, Jiyang Yu, Zhi Chen · 2019 · Molecules
  4. Tanshinone IIA ameliorates cognitive deficits by inhibiting endoplasmic reticulum stress-induced apoptosis in APP/PS1 transgenic mice
    Yingying He, John Bosco Ruganzu, Chengheng Lin, Bo Ding, Quzhao Zheng, Xiangyuan Wu, Ruiyang Ma, Qian Liu, Yang Wang, Hui Min Jin et al. · 2019 · Neurochemistry International
  5. Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer’s disease
    Kazuma Murakami · 2014 · Bioscience Biotechnology and Biochemistry
  6. A partial reduction of Drp1 improves cognitive behavior and enhances mitophagy, autophagy and dendritic spines in a transgenic Tau mouse model of Alzheimer disease
    Ramesh J. L. Kandimalla, Maria Mańczak, Jangampalli Adi Pradeepkiran, Hallie Morton, P. Hemachandra Reddy · 2021 · Human Molecular Genetics · Retracted
  7. Protein Tyrosine Phosphatase 1B (PTP1B): A Comprehensive Review of Its Role in Pathogenesis of Human Diseases
    Dominika Kołodziej, Łukasz Sobczak, Krzysztof Z. Łączkowski · 2024 · International Journal of Molecular Sciences
  8. Neuroprotective Effect ofBrassica oleraceaSprouts Crude Juice in a Cellular Model of Alzheimer’s Disease
    Alessandra Masci, Roberto Mattioli, Paolo Costantino, Simona Baima, Giorgio Morelli, Pasqualina Punzi, Cesare Giordano, Alessandro Pinto, Lorenzo M. Donini, Maria D’Erme et al. · 2015 · Oxidative Medicine and Cellular Longevity
  9. How does angiotensin AT2 receptor activation help neuronal differentiation and improve neuronal pathological situations?
    Marie‐Odile Guimond, Nicole Gallo‐Payet · 2012 · Frontiers in Endocrinology
  10. Formation of Dynamic Soluble Surfactant-induced Amyloid β Peptide Aggregation Intermediates
    Axel Abelein, Jørn Døvling Kaspersen, Søren B. Nielsen, Grethe Vestergaard Jensen, Gunna Christiansen, Jan Skov Pedersen, Jens Danielsson, Daniel E. Otzen, Astrid Gräslund · 2013 · Journal of Biological Chemistry
  11. Environmental enrichment eliminates the anxiety phenotypes in a triple transgenic mouse model of Alzheimer’s disease
    Susanna Pietropaolo, Joram Feldon, Benjamin K. Yee · 2014 · Cognitive Affective & Behavioral Neuroscience
  12. Alzheimer's disease amyloid beta converting left-handed Z-DNA back to right-handed B-form
    Jie Geng, Chuanqi Zhao, Jinsong Ren, Xiaogang Qu · 2010 · Chemical Communications
  13. Amyloid-β peptide-induced cytotoxicity and mitochondrial dysfunction in yeast
    Xin Chen, Dina Petranović · 2015 · FEMS Yeast Research
  14. Can Healthy Diets, Regular Exercise, and Better Lifestyle Delay the Progression of Dementia in Elderly Individuals?
    Elizabeth George, P. Hemachandra Reddy · 2019 · Journal of Alzheimer s Disease
  15. The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer’s Disease-related Pathogenesis
    Seong Gak Jeon, Anji Yoo, Dong Wook Chun, Sang Bum Hong, Hyunju Chung, Jin-Il Kim, Minho Moon · 2020 · Aging and Disease
  16. Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events
    Rajmohamed Mohamed Asik, Natarajan Suganthy, Mohamed Asik Aarifa, Arvind Kumar, Krisztián Szigeti, Domokos Máthé, Balázs Zoltán Gulyás, Govindaraju Archunan, Parasuraman Padmanabhan · 2021 · Biomedicines
  17. Expression of BC1 Impairs Spatial Learning and Memory in Alzheimer’s Disease Via APP Translation
    Zhang, Tongmei, Pang, Pei, Fang, Zemin, Guo, Yu, Li, Hao, Li, Xinyan, Tian, Tian, Yang, Xin, Chen, Wenting, Shu, Shu et al. · 2018 · Molecular Neurobiology
  18. A Reduced Astrocyte Response to β-Amyloid Plaques in the Ageing Brain Associates with Cognitive Impairment
    Mathur, Ryan, Ince, Paul G., Minett, Thais, Garwood, Claire J., Shaw, Pamela J., Matthews, Fiona E., Brayne, Carol, Simpson, Julie E., Wharton, Stephen B., on behalf of the MRC Cognitive Function and Ageing Neuropathology Study Group · 2015 · PLOS ONE
  19. Progressive signaling changes in the olfactory nerve of patients with Alzheimer's disease
    Praveen Bathini, Antoine Mottas, Muriel Jaquet, Emanuele Brai, Lavinia Auber Alberi · 2018 · Neurobiology of Aging
  20. Cognitive recovery by chronic activation of the large-conductance calcium-activated potassium channel in a mouse model of Alzheimer's disease
    Li Wang, Huicong Kang, Yongzhi Li, Yuan Shui, Ryo Yamamoto, Tokio Sugai, Nobuo Kato · 2015 · Neuropharmacology
  21. Mechanisms of U87 Astrocytoma Cell Uptake and Trafficking of Monomeric versus Protofibril Alzheimer’s Disease Amyloid-β Proteins
    Yali Li, Deshu Cheng, Ran Cheng, Xinyu Zhu, Tao Wan, Jianmiao Liu, Rongying Zhang · 2014 · PLoS ONE
  22. Alzheimer’s disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs
    Juan Manuel Zolezzi, Sussy Bastias Candia, Manuel J. Santos, Nibaldo C. Inestrosa · 2014 · Frontiers in Aging Neuroscience
  23. Redox Regulation of Protein Function via Cysteine S-Nitrosylation and Its Relevance to Neurodegenerative Diseases
    Mohd Waseem Akhtar, Carmen R. Sunico, Tomohiro Nakamura, Stuart A. Lipton · 2012 · International Journal of Cell Biology
  24. Sugar-Terminated Nanoparticle Chaperones Are 102–105 Times Better Than Molecular Sugars in Inhibiting Protein Aggregation and Reducing Amyloidogenic Cytotoxicity
    Nibedita Pradhan, Shashi Shekhar, Nihar Ranjan Jana, Nikhil Ranjan Jana · 2017 · ACS Applied Materials & Interfaces
  25. A Critical Assessment of Research on Neurotransmitters in Alzheimer’s Disease
    P. Hemachandra Reddy · 2017 · Journal of Alzheimer s Disease
  26. Pharmacophore-based models for therapeutic drugs against phosphorylated tau in Alzheimer’s disease
    Jangampalli Adi Pradeepkiran, Arubala P. Reddy, P. Hemachandra Reddy · 2018 · Drug Discovery Today
  27. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation
    Luka Kulic, Jordan McAfoose, Tobias Welt, Christian Tackenberg, Claudia B. Späni, Fabian Wirth, Verena H. Finder, Uwe Konietzko, M Giese, Anne Eckert et al. · 2012 · Translational Psychiatry
  28. Cognitive and emotional alterations in young Alzheimer's disease (3xTgAD) mice: Effects of neonatal handling stimulation and sexual dimorphism
    Toñi Cañete, Gloria Blázquez, Adolf Tobeña, Lydia Giménez‐Llort, Alberto Fernández‐Teruel · 2014 · Behavioural Brain Research
  29. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation
    Kailie Luan, Jesusa L. Rosales, Ki‐Young Lee · 2012 · Ageing Research Reviews
  30. Conformational targeting of intracellular Aβ oligomers demonstrates their pathological oligomerization inside the endoplasmic reticulum
    Giovanni Meli, Agnese Lecci, Annalisa Manca, Nina Krako Jakovljevic, Valentina Albertini, Luisa Benussi, Roberta Ghidoni, Antonino Cattaneo · 2014 · Nature Communications
  31. Tricyclic phenothiazine and phenoselenazine derivatives as potential multi-targeting agents to treat Alzheimer's disease
    Gary Tin, Tarek Mohamed, Nyasha Gondora, Michael A. Beazely, Praveen P. N. Rao · 2015 · MedChemComm
  32. Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task
    Tommaso Cassano, Silvio Calcagnini, Antonio Carbone, Vidyasagar Naik Bukke, Stanisław Orkisz, Rosanna Villani, Adele Romano, Carlo Avolio, Silvana Gaetani · 2019 · Frontiers in Pharmacology
  33. Protective Effects of Coenzyme Q10 Against Hydrogen Peroxide-Induced Oxidative Stress in PC12 Cell: The Role of Nrf2 and Antioxidant Enzymes
    Li Li, Jikun Du, Yaru Lian, Yun Liang Zhang, Xing‐Ren Li, Ying Liu, Liyi Zou, Tie Wu · 2015 · Cellular and Molecular Neurobiology
  34. Monoclonal Antibody Against the Turn of the 42-Residue Amyloid β-Protein at Positions 22 and 23
    Kazuma Murakami, Yuko Horikoshi‐Sakuraba, Nakaba Murata, Yoshihiro Noda, Yuichi Masuda, Noriaki Kinoshita, Hiroyuki Hatsuta, Shigeo Murayama, Takuji Shirasawa, Takahiko Shimizu et al. · 2010 · ACS Chemical Neuroscience
  35. SCM-198 inhibits microglial overactivation and attenuates Aβ1-40-induced cognitive impairments in rats via JNK and NF-кB pathways
    Zhenyi Hong, Xueru Shi, Kai Zhu, Tingting Wu, Yi Zhun Zhu · 2014 · Journal of Neuroinflammation
  36. A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics
    Rima Hajjo, Dima A. Sabbah, Osama H. Abusara, Abdel Qader Al Bawab · 2022 · Diagnostics
  37. Current understanding of metal-dependent amyloid-β aggregation and toxicity
    Yelim Yi, Mi Hee Lim · 2022 · RSC Chemical Biology
  38. NMR-based metabolomics of urine in a mouse model of Alzheimer’s disease: identification of oxidative stress biomarkers
    Kiyoshi Fukuhara, Akiko Ohno, Yosuke Ota, Yuya Senoo, Keiko Maekawa, Haruhiro Okuda, Masaaki Kurihara, Alato Okuno, Shumpei Niida, Yoshiro Saito et al. · 2013 · Journal of Clinical Biochemistry and Nutrition
  39. The Roles of Neutral Sphingomyelinases in Neurological Pathologies
    Charles R. Horres, Yusuf Awni Hannun · 2012 · Neurochemical Research
  40. The therapeutic potential of the endocannabinoid system for Alzheimer's disease
    Tim Karl, David Cheng, Brett Garner, Jonathon Carl Arnold · 2012 · Expert Opinion on Therapeutic Targets
  41. The effects of a series of carbon dots on fibrillation and cytotoxicity of human islet amyloid polypeptide
    Li Wang, Shoujun Zhu, Tong Lu, Guangji Zhang, Jia Xu, Yubin Song, Yang Li, Liping Wang, Bai Jun Yang, Fei Li · 2016 · Journal of Materials Chemistry B
  42. Roles of β-adrenergic receptors in Alzheimer's disease: Implications for novel therapeutics
    Jin‐Tai Yu, Naidong Wang, Teng Ma, Hong Fu Jiang, Jun Guan, Lan Tan · 2010 · Brain Research Bulletin
  43. Role of nutraceuticals on neurodegenerative diseases: neuroprotective and immunomodulant activity
    Angelo Fumia, Nicola Cicero, Marco Gitto, Noemi Nicosia, Alessio Alesci · 2021 · Natural Product Research
  44. Intercommunication between metal ions and amyloidogenic peptides or proteins in protein misfolding disorders
    Jong‐Min Suh, Mingeun Kim, Jeasang Yoo, Jiyeon Han, Cinthya Paulina, Mi Hee Lim · 2022 · Coordination Chemistry Reviews
  45. Towards Alzheimer's root cause: ECSIT as an integrating hub between oxidative stress, inflammation and mitochondrial dysfunction
    Montserrat Soler‐López, Nahuai Badiola, Andreas Zanzoni, Patrick Aloy · 2012 · BioEssays
  46. Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer’s disease
    Stefano Luca Sensi, Ilario Giovanni Rapposelli, Valério Frazzini, Nicola Mascetra · 2007 · Experimental Gerontology
  47. A Neuroprotective Brain-penetrating Endopeptidase Fusion Protein Ameliorates Alzheimer Disease Pathology and Restores Neurogenesis
    Brian J. Spencer, Inder M. Verma, Paula Desplats, Dinorah Friedmann‐Morvinski, Edward M. Rockenstein, Anthony Adame, Eliezer Masliah · 2014 · Journal of Biological Chemistry
  48. Epigenetic mechanisms of amyloid-β production in anisomycin-treated SH-SY5Y cells
    Xiufang Guo, Xiangmei Wu, Le-Ning Ren, Guangdong Liu, Lin Li · 2011 · Neuroscience
  49. FcγRIIb-SHIP2 axis links Aβ to tau pathology by disrupting phosphoinositide metabolism in Alzheimer's disease model
    Tae‐In Kam, Hyejin Park, Youngdae Gwon, Sungmin Song, Seo-Hyun Kim, Seo Won Moon, Dong‐Gyu Jo, Yong‐Keun Jung · 2016 · eLife
  50. Amyloid β Peptide Compromises Neural Stem Cell Fate by Irreversibly Disturbing Mitochondrial Oxidative State and Blocking Mitochondrial Biogenesis and Dynamics
    Maria Filipe Ribeiro, Tânia Genebra, Ana Cristina Rego, Cecília M. P. Rodrigues, Susana Solá · 2018 · Molecular Neurobiology
  51. MiR-9-5p inhibits mitochondrial damage and oxidative stress in AD cell models by targeting GSK-3β
    Liu, Junli, Zuo, Xiaoqin, Han, Jixiang, Dai, Qingxiang, Xu, Huining, Liu, Ying, Cui, Sen · 2020 · Bioscience, Biotechnology, and Biochemistry
  52. Degradation of FA reduces Aβ neurotoxicity and Alzheimer-related phenotypes
    Xuechao Fei, Yun Zhang, Yufei Mei, Xiangpei Yue, Wenjing Jiang, Li Ai, Yan Yu, Hongjun Luo, Hui Li, Wenhong Luo et al. · 2020 · Molecular Psychiatry
  53. Immunomodulation Targeting Abnormal Protein Conformation Reduces Pathology in a Mouse Model of Alzheimer's Disease
    Fernando Goñi, Frances Prelli, Yong Ji, Henrieta Scholtzova, Jing Yang, Yanjie Sun, Feng‐Xia Liang, Regina Kascsak, Richard J. Kascsak, Pankaj D Mehta et al. · 2010 · PLoS ONE
  54. A Multifaceted Role for apoE in the Clearance of Beta-Amyloid across the Blood-Brain Barrier
    Corbin J. Bachmeier, Daniel Paris, David Beaulieu‐Abdelahad, Benoit Mouzon, MICHAEL J. MULLAN, Fiona Crawford · 2012 · Neurodegenerative Diseases
  55. Macromolecular and small-molecule modulation of intracellular Aβ42 aggregation and associated toxicity
    Sohini Chakrabortee, Yun Liu, Liao Zhang, Helena R. Matthews, Hanrui Zhang, Ni Pan, Chun‐Ru Cheng, Shuhong Guan, De‐an Guo, Zebo Huang et al. · 2011 · Biochemical Journal
  56. Excess APP O -glycosylation by GalNAc-T6 decreases Aβ production
    Keiko Akasaka‐Manya, Masaki Kawamura, Hiroki Tsumoto, Yuko Saito, Yuriko Tachida, Shinobu Kitazume, Hiroyuki Hatsuta, Yuri Miura, Shin‐ichi Hisanaga, Shigeo Murayama et al. · 2016 · The Journal of Biochemistry
  57. Characterizing the structural ensemble of γ-secretase using a multiscale molecular dynamics approach
    Rodrigo Aguayo‐Ortiz, Cecilia Chávez-García, John E. Straub, Laura Domı́nguez · 2017 · Chemical Science
  58. Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membrane
    Liang Zhang, Sergey Trushin, Trace A. Christensen, Utkarsh Tripathi, Courtney C. Hong, Rachel E. Geroux, Kyle G. Howell, Joseph F. Poduslo, Eugenia V. Trushina · 2018 · Neurobiology of Disease
  59. Anti-Apoptotic Mechanisms of Acupuncture in Neurological Diseases: A Review
    Wa Cai, Wei-Dong Shen · 2018 · The American Journal of Chinese Medicine
  60. Impact of late-onset Alzheimer’s genetic risk factors on beta-amyloid endocytic production
    Cláudia Guimas Almeida, Farzaneh Sadat Mirfakhar, Catarina Perdigão, Tatiana Burrinha · 2018 · Cellular and Molecular Life Sciences
  61. An organic electrochemical transistor integrated with a molecularly selective isoporous membrane for amyloid-β detection
    Shofarul Wustoni, Shaofei Wang, Juan R. Alvarez, Tania Cecilia Hidalgo Castillo, Suzana P. Nunes, Sahika Inal · 2019 · Biosensors and Bioelectronics
  62. Mulberry Fruit Extract Alleviates Cognitive Impairment by Promoting the Clearance of Amyloid-β and Inhibiting Neuroinflammation in Alzheimer’s Disease Mice
    Dianxun Liu, Dongqing Du · 2020 · Neurochemical Research
  63. Formic acid is essential for immunohistochemical detection of aggregated intraneuronal Aβ peptides in mouse models of Alzheimer's disease
    Christensen, Ditte Z., Bayer, Thomas A., Wirths, Oliver · 2009 · Brain Research
  64. Distinct types of amyloid‐β oligomers displaying diverse neurotoxicity mechanisms in Alzheimer's disease
    Priyanka Madhu, Samrat Mukhopadhyay · 2021 · Journal of Cellular Biochemistry
  65. Role of Intracellular Amyloid β as Pathway Modulator, Biomarker, and Therapy Target
    Lucia Gallego Villarejo, Lisa Bachmann, David Marks, Maite Brachthäuser, Alexander Geidies, Thorsten Müller · 2022 · International Journal of Molecular Sciences
  66. The fate of interneurons, GABA A receptor sub‐types and perineuronal nets in Alzheimer's disease
    Afia B. Ali, Anam Islam, Andrew Constanti · 2022 · Brain Pathology
  67. C3N nanodots inhibits Aβ peptides aggregation pathogenic path in Alzheimer’s disease
    Xiuhua Yin, Hong Zhou, Mengling Zhang, Juan Su, Xiao Lu Wang, Sijie Li, Zaixing Yang, Zhenhui Kang, Ruhong Zhou · 2023 · Nature Communications
  68. Neurobiological aspects of Alzheimer's disease
    Kanwaljit Chopra, Shubham Misra, Anurag Kuhad · 2011 · Expert Opinion on Therapeutic Targets
  69. Long-term Dantrolene Treatment Reduced Intraneuronal Amyloid in Aged Alzheimer Triple Transgenic Mice
    Zhen Wu, Bin Yang, Chunxia Liu, Ge Liang, Weixia Liu, Stephen Pickup, Qingcheng Meng, Yuke Tian, Shitong Li, Maryellen Fazen Eckenhoff et al. · 2015 · Alzheimer Disease & Associated Disorders
  70. Optical Nanosensor for Intracellular and Intracranial Detection of Amyloid-Beta
    Merav Antman‐Passig, Eitan Wong, Georgia R. Frost, Christian Cupo, Janki Shah, Albert S. Agustinus, Ziyu Chen, Chiara D. Mancinelli, Maikel Kamel, Thomas Li et al. · 2022 · ACS Nano
  71. Ferritin light chain interacts with PEN-2 and affects γ-secretase activity
    Xinxin Li, Yiqian Liu, Qiuyang Zheng, Guorui Yao, Cheng Peng, Guojun Bu, Huaxi Xu, Yun‐wu Zhang · 2013 · Neuroscience Letters
  72. An effective treatment for Alzheimer's disease must consider both amyloid and tau
    Claire J. Lansdall · 2014 · Bioscience Horizons The International Journal of Student Research
  73. Development of new fusion proteins for visualizing amyloid-β oligomers in vivo
    Tomoyo Ochiishi, Motomichi Doi, Kazuhiko Yamasaki, Keiko Hirose, Akira Kitamura, Takao Urabe, Nobutaka Hattori, Masataka Kinjo, Tatsuhiko Ebihara, Hideki Shimura · 2016 · Scientific Reports
  74. Multifunctionality of self-assembled nanogels of curcumin-hyaluronic acid conjugates on inhibiting amyloid β-protein fibrillation and cytotoxicity
    Zhiqiang Jiang, Xiaoyan Dong, Hu Liu, Yongjian Wang, Lei Zhang, Yan Ping Sun · 2016 · Reactive and Functional Polymers
  75. Recombinant Antibody Fragments for Neurodegenerative Diseases
    Karen Manoutcharian, Roxanna Pérez-Garmendia, Goar Gevorkian · 2016 · Current Neuropharmacology
  76. Tautomeric Effect of Histidine on the Monomeric Structure of Amyloid β-Peptide(1–40)
    Hu Shi, Baotao Kang, Jin Yong Lee · 2016 · The Journal of Physical Chemistry B
  77. Down syndrome, beta-amyloid and neuroimaging
    Elizabeth Head, Alex M. Helman, David K. Powell, Frederick A. Schmitt · 2017 · Free Radical Biology and Medicine
  78. Concentration-dependent effects of mercury and lead on Aβ42: possible implications for Alzheimer’s disease
    Daniela Meleleo, Gabriella Notarachille, Vincenzo Mangini, Fabio Arnesano · 2019 · European Biophysics Journal
  79. Genetic Dissection of Alzheimer’s Disease Using Drosophila Models
    Young‐Jae Jeon, Jaeha Lee, Byoungyun Choi, So-Yoon Won, Kyoung Sang Cho · 2020 · International Journal of Molecular Sciences
  80. Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go
    Pragya Prasanna, Arun Upadhyay · 2021 · ACS Pharmacology & Translational Science
  81. Correlation between orphan nuclear receptor Nurr1 expression and amyloid deposition in 5 XFAD mice, an animal model of Alzheimer's disease
    Minho Moon, Inhye Jeong, Chun‐Hyung Kim, Jihong Kim, Paula K.J. Lee, Inhee Mook‐Jung, Pierre R Leblanc, Kwang‐Soo Kim · 2014 · Journal of Neurochemistry
  82. Drug Access to the Central Nervous System in Alzheimer’s Disease: Preclinical and Clinical Insights
    Dharmini C. Mehta, Jennifer Lynn Short, Sarah Nicole Hilmer, Joseph A. Nicolazzo · 2014 · Pharmaceutical Research
  83. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding
    Benjamin Shackleton, Fiona Crawford, Corbin J. Bachmeier · 2016 · Fluids and Barriers of the CNS
  84. ANK1 is up-regulated in laser captured microglia in Alzheimer’s brain; the importance of addressing cellular heterogeneity
    Diego Mastroeni, Shobana Sekar, Jennifer Nolz, Elaine Delvaux, Katie Lunnon, Jonathan S. Mill, Winnie S. Liang, Paul D. Coleman · 2017 · PLoS ONE
  85. Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer’s Disease
    Christopher Bi, Stephanie Bi, Bin Li · 2018 · Aging and Disease
  86. Membrane-mimetic systems for biophysical studies of the amyloid-β peptide
    Nicklas Österlund, Jinghui Luo, Sebastian K.T.S. Wärmländer, Astrid Gräslund · 2018 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  87. Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin
    Rajni Parthasarathy, K. Martin Chow, Zahra Derafshi, Michael P. Fautsch, John R. Hetling, David W. Rodgers, Louis B. Hersh, David R. Pepperberg · 2015 · Experimental Eye Research
  88. Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease
    Amandine EB, Yannick Marchalant · 2015 · Aging and Disease
  89. Towards a whole-body systems [multi-organ] lipidomics in Alzheimer’s disease
    Giuseppe Astarita, Daniele Piomelli · 2011 · Prostaglandins Leukotrienes and Essential Fatty Acids
  90. Mitogen-activated protein kinase signaling pathways are involved in regulating α7 nicotinic acetylcholine receptor-mediated amyloid-β uptake in SH-SY5Y cells
    Weina Yang, Kai Ma, X.L. Chen, Lili Shi, Guojun Bu, X.D. Hu, H. Han, Yundie Liu, Yi‐Hua Qian · 2014 · Neuroscience
  91. The central molecular clock is robust in the face of behavioural arrhythmia in aDrosophilamodel of Alzheimer's disease
    Ko‐Fan Chen, Bernard P. Possidente, David A. Lomas, Damian C. Crowther · 2014 · Disease Models & Mechanisms
  92. Accumulation of Amyloid-Like Aβ 1–42 in AEL (Autophagy–Endosomal–Lysosomal) Vesicles: Potential Implications for Plaque Biogenesis
    Daijun Ling, Martha Magallanes, Paul M. Salvaterra · 2014 · ASN NEURO
  93. The Bri2 and Bri3 BRICHOS Domains Interact Differently with Aβ 42 and Alzheimer Amyloid Plaques
    Lisa Dolfe, Simone Tambaro, Helene Tigro, Marta del Campo, Jeroen J.M. Hoozemans, Birgitta Wiehager, Caroline Graff, Bengt G. Winblad, Maria Ankarcrona, Margit Kaldmäe et al. · 2018 · Journal of Alzheimer s Disease Reports
  94. Heterochromatic genome instability and neurodegeneration sharing similarities with Alzheimer’s disease in old Bmi1+/− mice
    Jida El Hajjar, Wassim Chatoo, Roy Hanna, Patrick Nkanza, Nicolas Tétreault, Yiu Chung Tse, Tak Pan Wong, Mohamed Abdouh, Gilbert Bernier · 2019 · Scientific Reports
  95. The therapeutic potential of exercise for neuropsychiatric diseases: A review
    Sabrina Swenson, Kenneth Blum, Thomas McLaughlin, Mark S. Gold, Panayotis K. Thanos · 2020 · Journal of the Neurological Sciences
  96. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration
    Chu Hsien Lim, Prameet Kaur, Emelyne Teo, Vanessa Yuk Man Lam, Fangchen Zhu, Caroline Kibat, Jan Gruber, Ajay Sriram Mathuru, Nicholas S. Tolwinski · 2020 · eLife
  97. The Role of APP O-Glycosylation in Alzheimer’s Disease
    Keiko Akasaka‐Manya, Hiroshi Manya · 2020 · Biomolecules
  98. Serotonin and Melatonin Show Different Modes of Action on Aβ42 Protofibril Destabilization
    Yehong Gong, Chendi Zhan, Yu Feng Zou, Zhenyu Qian, Guanghong Wei, Qingwen Zhang · 2021 · ACS Chemical Neuroscience
  99. Transport of Alzheimer’s associated amyloid-β catalyzed by P-glycoprotein
    James W. McCormick, Lauren A McCormick, Gang Chen (党陈), Pia D. Vogel, John G. Wise · 2021 · PLoS ONE
  100. Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide(1–42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function
    Francesco Misiti, Maria Elisabetta Clementi, Bruno Giardina · 2010 · Neurochemistry International